Funder
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Tufts University
American Heart Association
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Chatterjee, K., Zhang, J., Honbo, N. & Karliner, J. S. Doxorubicin cardiomyopathy. Cardiology 115, 155–162 (2010).
2. Nebigil, C. G. & Désaubry, L. Updates in anthracycline-mediated cardiotoxicity. Front. Pharmacol. 9, 1262 (2018).
3. Bennett, P., Williamson, P. & Taylor, R. Review of canine lymphoma treated with chemotherapy—outcomes and prognostic factors. Vet. Sci. 10, 342 (2023).
4. Henriksen, P. A. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart 104, 971–977 (2018).
5. Brown, S., Okwuosa, T. M., Barac, A. & Volgman, A. S. The role of angiotensin‐converting enzyme inhibitors and β‐blockers in primary prevention of cardiac dysfunction in breast cancer patients. J. Am. Heart Assoc. 9, e015327 (2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献